Suppressing Cdk5 Activity by Luteolin Inhibits MPP<sup>+</sup>-Induced Apoptotic of Neuroblastoma through Erk/Drp1 and Fak/Akt/GSK3β Pathways
Parkinson’s disease (PD) is characterized by the progressive degeneration of dopaminergic neurons. The cause of PD is still unclear. Oxidative stress and mitochondrial dysfunction have been linked to the development of PD. Luteolin, a non-toxic flavonoid, has become interested in an alternative medi...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/5/1307 |
id |
doaj-dd3e77e3948c4d18a9d4993a3ecbd7b4 |
---|---|
record_format |
Article |
spelling |
doaj-dd3e77e3948c4d18a9d4993a3ecbd7b42021-03-01T00:04:26ZengMDPI AGMolecules1420-30492021-02-01261307130710.3390/molecules26051307Suppressing Cdk5 Activity by Luteolin Inhibits MPP<sup>+</sup>-Induced Apoptotic of Neuroblastoma through Erk/Drp1 and Fak/Akt/GSK3β PathwaysRatchaneekorn Reudhabibadh0Thunwa Binlateh1Pennapa Chonpathompikunlert2Nongyao Nonpanya3Peerada Prommeenate4Pithi Chanvorachote5Pilaiwanwadee Hutamekalin6Division of Health and Applied Sciences, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90110, ThailandDivision of Health and Applied Sciences, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90110, ThailandExpert Centre of Innovative Health Food (InnoFood), Thailand Institute of Scientific and Technological Research (TISTR), Khlong Luang, Pathum Thani 12120, ThailandCell-based Drug and Health Products Development Research Unit, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, ThailandBiochemical Engineering and Systems Biology Research Group, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency at King Mongkut’s University of Technology Thonburi, Bangkok 10150, ThailandCell-based Drug and Health Products Development Research Unit, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, ThailandDivision of Health and Applied Sciences, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90110, ThailandParkinson’s disease (PD) is characterized by the progressive degeneration of dopaminergic neurons. The cause of PD is still unclear. Oxidative stress and mitochondrial dysfunction have been linked to the development of PD. Luteolin, a non-toxic flavonoid, has become interested in an alternative medicine, according to its effects on anti-oxidative stress and anti-apoptosis, although the underlying mechanism of luteolin on PD has not been fully elucidated. This study aims to investigate whether luteolin prevents neurotoxicity induction by 1-methyl-4-phenylpyridinium iodide (MPP<sup>+</sup>), a neurotoxin in neuroblastoma SH-SY5Y cells. The results reveal that luteolin significantly improved cell viability and reduced apoptosis in MPP<sup>+</sup>-treated cells. Increasing lipid peroxidation and superoxide anion (O<sub>2</sub><sup>ˉ</sup>), including mitochondrial membrane potential (Δψm) disruption, is ameliorated by luteolin treatment. In addition, luteolin attenuated MPP<sup>+</sup>-induced neurite damage via GAP43 and synapsin-1. Furthermore, Cdk5 is found to be overactivated and correlated with elevation of cleaved caspase-3 activity in MPP<sup>+</sup>-exposed cells, while phosphorylation of Erk1/2, Drp1, Fak, Akt and GSK3β are inhibited. In contrast, luteolin attenuated Cdk5 overactivation and supported phosphorylated level of Erk1/2, Drp1, Fak, Akt and GSK3β with reducing in cleaved caspase-3 activity. Results indicate that luteolin exerts neuroprotective effects via Cdk5-mediated Erk1/2/Drp1 and Fak/Akt/GSK3β pathways, possibly representing a potential preventive agent for neuronal disorder.https://www.mdpi.com/1420-3049/26/5/13071-methyl-4-phenylpyridinium ionapoptosisCdk5luteolinoxidative stressParkinson’s disease |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ratchaneekorn Reudhabibadh Thunwa Binlateh Pennapa Chonpathompikunlert Nongyao Nonpanya Peerada Prommeenate Pithi Chanvorachote Pilaiwanwadee Hutamekalin |
spellingShingle |
Ratchaneekorn Reudhabibadh Thunwa Binlateh Pennapa Chonpathompikunlert Nongyao Nonpanya Peerada Prommeenate Pithi Chanvorachote Pilaiwanwadee Hutamekalin Suppressing Cdk5 Activity by Luteolin Inhibits MPP<sup>+</sup>-Induced Apoptotic of Neuroblastoma through Erk/Drp1 and Fak/Akt/GSK3β Pathways Molecules 1-methyl-4-phenylpyridinium ion apoptosis Cdk5 luteolin oxidative stress Parkinson’s disease |
author_facet |
Ratchaneekorn Reudhabibadh Thunwa Binlateh Pennapa Chonpathompikunlert Nongyao Nonpanya Peerada Prommeenate Pithi Chanvorachote Pilaiwanwadee Hutamekalin |
author_sort |
Ratchaneekorn Reudhabibadh |
title |
Suppressing Cdk5 Activity by Luteolin Inhibits MPP<sup>+</sup>-Induced Apoptotic of Neuroblastoma through Erk/Drp1 and Fak/Akt/GSK3β Pathways |
title_short |
Suppressing Cdk5 Activity by Luteolin Inhibits MPP<sup>+</sup>-Induced Apoptotic of Neuroblastoma through Erk/Drp1 and Fak/Akt/GSK3β Pathways |
title_full |
Suppressing Cdk5 Activity by Luteolin Inhibits MPP<sup>+</sup>-Induced Apoptotic of Neuroblastoma through Erk/Drp1 and Fak/Akt/GSK3β Pathways |
title_fullStr |
Suppressing Cdk5 Activity by Luteolin Inhibits MPP<sup>+</sup>-Induced Apoptotic of Neuroblastoma through Erk/Drp1 and Fak/Akt/GSK3β Pathways |
title_full_unstemmed |
Suppressing Cdk5 Activity by Luteolin Inhibits MPP<sup>+</sup>-Induced Apoptotic of Neuroblastoma through Erk/Drp1 and Fak/Akt/GSK3β Pathways |
title_sort |
suppressing cdk5 activity by luteolin inhibits mpp<sup>+</sup>-induced apoptotic of neuroblastoma through erk/drp1 and fak/akt/gsk3β pathways |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2021-02-01 |
description |
Parkinson’s disease (PD) is characterized by the progressive degeneration of dopaminergic neurons. The cause of PD is still unclear. Oxidative stress and mitochondrial dysfunction have been linked to the development of PD. Luteolin, a non-toxic flavonoid, has become interested in an alternative medicine, according to its effects on anti-oxidative stress and anti-apoptosis, although the underlying mechanism of luteolin on PD has not been fully elucidated. This study aims to investigate whether luteolin prevents neurotoxicity induction by 1-methyl-4-phenylpyridinium iodide (MPP<sup>+</sup>), a neurotoxin in neuroblastoma SH-SY5Y cells. The results reveal that luteolin significantly improved cell viability and reduced apoptosis in MPP<sup>+</sup>-treated cells. Increasing lipid peroxidation and superoxide anion (O<sub>2</sub><sup>ˉ</sup>), including mitochondrial membrane potential (Δψm) disruption, is ameliorated by luteolin treatment. In addition, luteolin attenuated MPP<sup>+</sup>-induced neurite damage via GAP43 and synapsin-1. Furthermore, Cdk5 is found to be overactivated and correlated with elevation of cleaved caspase-3 activity in MPP<sup>+</sup>-exposed cells, while phosphorylation of Erk1/2, Drp1, Fak, Akt and GSK3β are inhibited. In contrast, luteolin attenuated Cdk5 overactivation and supported phosphorylated level of Erk1/2, Drp1, Fak, Akt and GSK3β with reducing in cleaved caspase-3 activity. Results indicate that luteolin exerts neuroprotective effects via Cdk5-mediated Erk1/2/Drp1 and Fak/Akt/GSK3β pathways, possibly representing a potential preventive agent for neuronal disorder. |
topic |
1-methyl-4-phenylpyridinium ion apoptosis Cdk5 luteolin oxidative stress Parkinson’s disease |
url |
https://www.mdpi.com/1420-3049/26/5/1307 |
work_keys_str_mv |
AT ratchaneekornreudhabibadh suppressingcdk5activitybyluteolininhibitsmppsupsupinducedapoptoticofneuroblastomathrougherkdrp1andfakaktgsk3bpathways AT thunwabinlateh suppressingcdk5activitybyluteolininhibitsmppsupsupinducedapoptoticofneuroblastomathrougherkdrp1andfakaktgsk3bpathways AT pennapachonpathompikunlert suppressingcdk5activitybyluteolininhibitsmppsupsupinducedapoptoticofneuroblastomathrougherkdrp1andfakaktgsk3bpathways AT nongyaononpanya suppressingcdk5activitybyluteolininhibitsmppsupsupinducedapoptoticofneuroblastomathrougherkdrp1andfakaktgsk3bpathways AT peeradaprommeenate suppressingcdk5activitybyluteolininhibitsmppsupsupinducedapoptoticofneuroblastomathrougherkdrp1andfakaktgsk3bpathways AT pithichanvorachote suppressingcdk5activitybyluteolininhibitsmppsupsupinducedapoptoticofneuroblastomathrougherkdrp1andfakaktgsk3bpathways AT pilaiwanwadeehutamekalin suppressingcdk5activitybyluteolininhibitsmppsupsupinducedapoptoticofneuroblastomathrougherkdrp1andfakaktgsk3bpathways |
_version_ |
1724247198896488448 |